v3 Template
P
Poplar Therapeutics, Inc.
Biotechnology/Pharmaceuticals
Founded
--
Employees
--
Total Funding
$45.0M
Funding Rounds
1
Last Funding
2026-03-03
About Poplar Therapeutics, Inc.
Poplar Therapeutics is on a mission to create the next generation of anti-IgE medicines to help patients live free of fear from related conditions.
Products & Services
Anti-IgE Medicines: Next-generation medications designed to help patients manage conditions related to IgE without fear.
Specialties
Anti-IgE Medicine Development
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A Extension T: - FT: Series A Extension |
A: 45000000 MR: - FA: $45 million FAN: 45000000 |
D: 2026-03-03 FD: 2026-03-03 |
5 investors |
Series A Extension
Latest
2026-03-03
$45.0M
5 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Poplar Therapeutics, Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- poplartx.com
- Industries
- Biotechnology/Pharmaceuticals
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro